Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.04%
#2 Ocean Protocol Ocean Protocol +17.97%
#3 KUB Coin KUB Coin +16.96%
#4 Geodnet Geodnet +13.43%
#5 Audiera Audiera +12.11%
#6 Not in Employment, Education, or Training Not in Employment, Education, or Training +8.18%
#7 DexNet DexNet +7.78%
#8 Cysic Cysic +7.16%
#9 Ontology Gas Ontology Gas +6.91%
#10 Arowana Arowana +6.80%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Настройки
Язык
Pусский
Валюта
USD
Тема
CytoMed Therapeutics Limited CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC
Ранг среди акций #32324
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical... CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
Цена акции
$0.88
Последняя синхронизация: 2026-08-17
Рыночная капитализация
$10.41M
Изменение (1 день)
-7.26%
Изменение (1 год)
-50.56%
Страна
SG
Торговля CytoMed Therapeutics Limited (GDTC)

Категория

Healthcare
Выручка компании CytoMed Therapeutics Limited (GDTC)
Выручка на Aug 2026 TTM: 0
Согласно последним финансовым отчетам CytoMed Therapeutics Limited, текущая выручка компании (TTM) составляет 0. В 2026 году компания получила выручку 0 равна выручке в 2026 году, которая составила 0. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки CytoMed Therapeutics Limited с 2026 по 2026
Выручка на конец каждого года
Год Выручка Изменить
Недостаточно данных для указанных дат.
Выручка аналогичных компаний или конкурентов
Компания Выручка Разница в выручке Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR